Intervention of Air Pollution and Acute Coronary Syndrome

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

200 participants

Study Classification

INTERVENTIONAL

Study Start Date

2019-04-10

Study Completion Date

2022-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

To determine the effect of intervention of ambient air pollution on acute coronary syndrome patients.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Early Use of Noninvasive Positive Pressure Ventilation for Intro-pulmonary Acute Lung Injury

NCT01581229

Acute Lung Injury

COMPLETED NA

Bedside Air Quality in ICU and Clinical Outcome

NCT06201754

Critical Illness

WITHDRAWN

Aerosol Therapy in Intensive Care Units

NCT03597334

Respiration, Artificial Critical Care

COMPLETED

Predictors of Non-invasive Ventilation Failure in Patients With Acute Cardiogenic Pulmonary Edema

NCT02653365

Acute Cardiogenic Pulmonary Edema

COMPLETED

Management of Noninvasive Ventilation in Hypoxemic Patients

NCT03250416

Noninvasive Ventilation

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

To investgate the effect of wearing facemasks to decreasing levels of exposure to ambient air on acute coronary syndrome patients.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Acute Coronary Syndrome

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

PREVENTION

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

no masking

not wearing facemask

Group Type SHAM_COMPARATOR

mask

Intervention Type DEVICE

facemask

masking

wearing facemask

Group Type ACTIVE_COMPARATOR

mask

Intervention Type DEVICE

facemask

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

mask

facemask

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Non-smoker of any type during past six months and living in a non-smoking household.
2. A diagnosis of myocardial infarction or unstable angina 7-90 days prior to signed informed consent.

Exclusion Criteria

1. Unstable CV disorders including uncompensated heart failure, refractory angina, uncontrolled arrhythmias, critical valvular heart disease and severe hypertension.
2. A history of infection with human immunodeficiency virus.
3. History of malignancy including leukemia and lymphoma AND/OR any severe, life-threatening disease AND/OR history of drug abuse within the last 2 years.
4. Pregnancy or intent to get pregnant during the study period.

Minimum Eligible Age

18 Years

Maximum Eligible Age

80 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No